Hélène Decaluwe

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Cell Cycle Arrest

Top Venues

Nature communications

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Damien Maggiorani, Oanh Le, Véronique Lisi, Séverine Landais, Gaël Moquin-Beaudry, Vincent-Philippe Lavallée, Hélène Decaluwe, Christian Beauséjour
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment. Nature communications 15 (1) (2024)
Damien Maggiorani, Oanh Le, Véronique Lisi, Séverine Landais, Gaël Moquin-Beaudry, Vincent-Philippe Lavallée, Hélène Decaluwe, Christian Beauséjour
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment. Nature communications 15 (1) (2024)
Damien Maggiorani, Oanh Le, Véronique Lisi, Séverine Landais, Gaël Moquin-Beaudry, Vincent-Philippe Lavallée, Hélène Decaluwe, Christian Beauséjour
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment. Nature communications 15 (1) (2024)
Damien Maggiorani, Oanh Le, Véronique Lisi, Séverine Landais, Gaël Moquin-Beaudry, Vincent-Philippe Lavallée, Hélène Decaluwe, Christian Beauséjour
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment. Nature communications 15 (1) (2024)
Louis Marois, Fabien Touzot, Elie Haddad, Isabel Fernandez, Marie-Paule Morin, Jean Jacques De Bruycker, Michel Duval, Sonia Cellot, Pierre Teira, Henrique Bittencourt, Hélène Decaluwe
Successful management of familial hemophagocytic lymphohistiocytosis by the JAK 1/2 inhibitor ruxolitinib. Pediatric blood & cancer 68 (6) (2021)